SUN PHARMACEUTICAL INDUSTRIES
Back to Balance Sheet
|
SUN PHARMACEUTICAL INDUSTRIES Last 5 Year Deferred Tax Assets / Liabilities History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Deferred Tax Assets / Liabilities | ₹-3,949 Cr | ₹-3,487 Cr | ₹-2,818 Cr | ₹-3,512 Cr | ₹-3,117 Cr |
What is the latest Deferred Tax Assets / Liabilities ratio of SUN PHARMACEUTICAL INDUSTRIES ?
Year | Deferred Tax Assets / Liabilities |
---|---|
Mar2024 | ₹-3,949 Cr |
Mar2023 | ₹-3,487 Cr |
Mar2022 | ₹-2,818 Cr |
Mar2021 | ₹-3,512 Cr |
Mar2020 | ₹-3,117 Cr |
How is Deferred Tax Assets / Liabilities of SUN PHARMACEUTICAL INDUSTRIES Trending?
Years | Deferred Tax Assets / Liabilities | % Change | |
---|---|---|---|
Mar2024 | ₹-3,949 Cr | Negative | |
Mar2023 | ₹-3,487 Cr | Negative | |
Mar2022 | ₹-2,818 Cr | Negative | |
Mar2021 | ₹-3,512 Cr | Negative | |
Mar2020 | ₹-3,117 Cr | - |
Compare Deferred Tax Assets / Liabilities of peers of SUN PHARMACEUTICAL INDUSTRIES
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
SUN PHARMACEUTICAL INDUSTRIES | ₹418,222.0 Cr | -2.4% | -7.2% | 27.2% | Stock Analytics | |
DIVIS LABORATORIES | ₹148,023.0 Cr | 0% | -9.2% | 61.5% | Stock Analytics | |
CIPLA | ₹119,474.0 Cr | 6% | -3.8% | 10.7% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹101,599.0 Cr | 1.7% | -11.4% | 2.2% | Stock Analytics | |
MANKIND PHARMA | ₹100,540.0 Cr | -0.9% | -16% | 21% | Stock Analytics | |
ZYDUS LIFESCIENCES | ₹97,604.7 Cr | 5.2% | -2.1% | 26.1% | Stock Analytics |
SUN PHARMACEUTICAL INDUSTRIES Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
SUN PHARMACEUTICAL INDUSTRIES | -2.4% |
-7.2% |
27.2% |
SENSEX | 1.7% |
-1.3% |
7.7% |
You may also like the below Video Courses